1442025
Last Update Posted: 2015-08-11
Recruiting has ended
All Genders accepted | 18 Years + |
121 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease
To investigate whether sustained trough levels of IFX can be achieved using IFX (Infliximab) trough level measurements and adjustment of dosing based upon these levels by means of two different standardized algorithms in comparison with 'standard of care' IFX treatment and its effects on clinical and endoscopic outcomes.
Eligibility
Relevant conditions:
Crohn's Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov